equinet Analysts Give Gerresheimer (GXI) a €69.00 Price Target
Gerresheimer (ETR:GXI) received a €69.00 ($80.23) price target from equities research analysts at equinet in a report issued on Monday. The firm presently has a “neutral” rating on the stock. equinet’s price target indicates a potential downside of 2.61% from the company’s previous close.
GXI has been the topic of a number of other research reports. Deutsche Bank reissued a “buy” rating on shares of Gerresheimer in a research report on Friday. JPMorgan Chase & Co. set a €72.00 ($83.72) price target on Gerresheimer and gave the stock a “neutral” rating in a research report on Wednesday, July 18th. Commerzbank set a €68.00 ($79.07) price target on Gerresheimer and gave the stock a “neutral” rating in a research report on Thursday, June 21st. Credit Suisse Group set a €88.00 ($102.33) price target on Gerresheimer and gave the stock a “buy” rating in a research report on Monday, September 17th. Finally, Berenberg Bank set a €85.00 ($98.84) price target on Gerresheimer and gave the stock a “buy” rating in a research report on Friday, July 27th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of €72.67 ($84.50).
GXI opened at €70.85 ($82.38) on Monday. Gerresheimer has a 12-month low of €59.97 ($69.73) and a 12-month high of €78.25 ($90.99).
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Recommended Story: What are the reasons investors use put options?
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.